Participant Database for Autism Research Studies
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00549731 |
Recruitment Status :
Recruiting
First Posted : October 26, 2007
Last Update Posted : September 18, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Autism Spectrum Disorder |
Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities
Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group
Aim 3: to maintain subject information in a database, from which we can recruit for our studies
Study Type : | Observational |
Estimated Enrollment : | 120 participants |
Observational Model: | Other |
Time Perspective: | Other |
Official Title: | Database for Persons Interested in Research Studies of Developmental Disorders |
Actual Study Start Date : | June 2013 |
Estimated Primary Completion Date : | June 2023 |
Estimated Study Completion Date : | June 2023 |

Group/Cohort |
---|
Healthy individuals
No intervention Healthy participants ages 14-32 for a neuroimaging study. |
Individuals with Autism Spectrum Disorder
No intervention ASD participants ages 14-32 for a neuroimaging study. |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 14 Years to 32 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Typically-developing, healthy adolescents and adults (ages 14-32)
- Adolescents and adults with autism spectrum disorder (ages 14-32)
Exclusion Criteria:
- Extreme premature birth (<34 weeks)
- Known genetic disorders related to autism (e.g. Fragile X)
- Recent diagnosis of psychosis (within 6 months)
- Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome).
- Metal implants / permanent retainers / hair dyes with metallic components

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00549731
Contact: Nicole McGuiggan, Rsch Coord | 617-966-9766 | TRANSCEND@partners.org |
United States, Massachusetts | |
Martinos Center of Biomedical Imaging | Recruiting |
Charlestown, Massachusetts, United States, 02129 |
Principal Investigator: | Tal Kenet, Ph.D | Massachusetts General Hospital |
Responsible Party: | Tal Kenet, Associate Professor, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT00549731 |
Other Study ID Numbers: |
2007-P-000062 5R01MH117998 ( U.S. NIH Grant/Contract ) |
First Posted: | October 26, 2007 Key Record Dates |
Last Update Posted: | September 18, 2020 |
Last Verified: | September 2020 |
autism autistic language |
development developmental assessment |
Autistic Disorder Autism Spectrum Disorder Child Development Disorders, Pervasive Neurodevelopmental Disorders Mental Disorders |